Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2212-2218

  Soh, Shigehiro ^a   Kattan, Michael W ^a   Berkman, Scott ^a   Wheeler, Thomas M ^a   Scardino, Peter T ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

neoplasm staging; prostate specific antigen; prostatectomy; prostatic neoplasms; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030945818     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64721-9     Document Type: Article

References (24)

1. Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
2. Ohori, M., Wheeler, T. M., Dunn, J. K., Stamey, T. A. and Scardino, P. T.: The pathologic features and prognosis of prostate cancer detectable with current diagnostic tests. J. Urol., 152: 1714, 1994.
3. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The new American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer, 74: 104, 1994.
4. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
5. Trapasso, J. G., deKernion, J. B., Smith, R. B. and Dorey, F.: The incidence and significance of detectable level of serum prostate specific antigen after radical prostatectomy. J. Urol., 152: 1821, 1994.
6. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
7. Silverberg, E., Boring, C. C. and Squires, T. S.: Cancer statistics, 1990. CA, 40: 9, 1990.
8. Parker, S. L., Tong, T., Bolden, S. and Wingo, R. A.: Cancer statistics, 1997. CA, 47: 5, 1997.
9. Lu-Yao, G. L., McLerran, D., Wasson, J. H., Wennberg, J. E. for the Prostate Patient Outcomes Research Team: An assessment of radical prostatectomy: time trends, geographic variation, and outcomes. J.A.M.A., 269: 2633, 1993.
10. Potosky, A. L., Miller, B. A., Albertsen, P. C. and Kramer, B. S.: The role of increasing detection in the rising incidence of prostate cancer. J.A.M.A., 273: 548, 1995.
11. Scardino, P. T., Weaver, R. and Hudson, M. A.: Early detection of prostate cancer. Hum. Path., 23: 211, 1992.
12. Wheeler, T. M.: Anatomy of the prostate and the pathology of prostate cancer. In: Comprehensive Textbook of Genitourinary Oncology. Edited by N. J. Vogelzang, P. T. Scardino, W. U. Shipley and D. S. Coffey. Baltimore: Williams & Wilkins, pp. 621-639, 1996.
13. Greene, D. R., Wheeler, T. M., Egawa, S., Dunn, J. K. and Scardino, P. T.: A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J. Urol., 146: 1069, 1991.
14. Epstein, J. I., Carmichael, M. J., Pizov, G. and Walsh, P. C.: Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J. Urol., 150: 135, 1993.
15. Petros, J. A. and Catalona, W. J.: Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J. Urol., 147: 1574, 1992.
16. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
17. Rogers, E., Eastham, J. A., Ohori, M., Sariyuce, O., Aihara, M., Wheeler, T. M. and Scardino, P. T.: Impalpable prostate cancer: clinicopathological features. Brit. J. Urol., 77: 429, 1996.
18. Ohori, M., Goad, J. R., Wheeler, T. M., Eastham, J. A., Thompson, T. C. and Scardino, P. T.: Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J. Urol., 152: 1843, 1994.
19. Kramer, B. S., Brown, M. L., Prorok, P. C., Potosky, A. L. and Gohagan, J. K.: Prostate cancer screening: what we know and what we need to know. Ann. Intern. Med., 119: 914, 1993.
20. Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A. and Whittemore, A. S.: Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer, suppl., 71: 933, 1993.
21. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. J.A.M.A., 273: 289, 1995.
22. Stamey, T. A.: Making the most out of six systematic sextant biopsies. Urology, 45: 2, 1995.
23. Ohori, M., Wheeler, T. M., Kattan, M. W., Goto, Y. and Scardino, P. T.: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol., 154: 1818, 1995.
24. Kosary, C. L., Ries, L. A. G., Miller, B. A., Hankey, B. F., Harras, A. and Edwards, B. K.: SEER Cancer Statistics Review, 1973-1992. NIH Publication No. 96-2789. Bethesda, Maryland: United States Department of Health and Human Services, 1996.